Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: DBV Technologies

Viaskin Peanut “Patch” Therapy Takes Next Step Toward Approval… in Europe

FDA Denies Approval of Viaskin Peanut “Patch” Therapy

Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...

FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...

DBV Technologies Reports Positive Three-Year, Long Term Data from Phase III...

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut...

FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy

DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut...

Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies

Your School On Our Map

Put Your School on the Map